Alexander Gonzalez-Pedroza
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels.
Journal: Scientific reports
Published: July 12, 2018
Prognostic value of intra-tumoral CD8+ /FoxP3+ lymphocyte ratio in patients with resected colorectal cancer liver metastasis.
Journal: Journal of surgical oncology
Published: February 16, 2018
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Journal: Gastroenterology
Published: December 02, 2016
GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cells ex vivo.
Journal: Oncoimmunology
Published: January 29, 2015
Multipotent mesenchymal stromal cells in liver cancer: implications for tumor biology and therapy.
Journal: Biochimica et biophysica acta
Published: May 01, 2014
Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma.
Journal: Carcinogenesis
Published: June 07, 2013
Overestimation of hematopoietic stem cell frequencies in human liver grafts.
Journal: Hepatology (Baltimore, Md.)
Published: November 01, 2012
Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer.
Journal: Hepatology (Baltimore, Md.)
Published: March 14, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026